Sozio, F <br/><br/>
Efficacy and safety of a salvage regimen based on tipranavir, enfuvirtide and three nucleoside analogues in HIV1 infected patients with clinical progression: 96-week evaluation.  [electronic resource] 

 -  Le infezioni in medicina  Dec 2009 
 - 228-35 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1124-9390 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Algorithms<br/>Anti-HIV Agents--therapeutic use<br/>Antiretroviral Therapy, Highly Active<br/>CD4 Lymphocyte Count<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Disease Progression<br/>Enfuvirtide<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>HIV Envelope Protein gp41--therapeutic use<br/>HIV Fusion Inhibitors--therapeutic use<br/>HIV Infections--drug therapy<br/>HIV-1<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Peptide Fragments--therapeutic use<br/>Phenotype<br/>Pyridines--therapeutic use<br/>Pyrones--therapeutic use<br/>Salvage Therapy<br/>Sulfonamides<br/>Time Factors<br/>Treatment Outcome